kappa opioid receptor antagonist

This page covers all kappa opioid receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting kappa opioid receptor.

Targets

kappa opioid receptor

Phase 3 pipeline (2)

• Q8003 · QRxPharma Inc. · Psychiatry
  Q8003 is a selective inhibitor of the kappa opioid receptor.
• YM060 · Astellas Pharma Inc · Pain
  YM060 is a selective and potent kappa opioid receptor antagonist.

Patent intelligence

• kappa opioid receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates